TitleA potential role for the CDH13/CDH15 gene in repeat revascularization after first percutaneous coronary intervention
AuthorsXiang, Qian
Liu, Zhiyan
Lu, Yun
Mao, Jie
Chen, Shuqing
Zhao, Xun
Zhou, Shuang
Xie, Qiufen
Wang, Zining
Mu, Guangyan
Jiang, Jie
Gong, Yanjun
Cui, Yimin
AffiliationPeking Univ, Hosp 1, Dept Pharm, 6 Da Hong Luo Chang St, Beijing 100034, Peoples R China
Hennepin Cty Med Ctr, Dept Pharm, 701 Pk Ave, Minneapolis, MN 55415 USA
Gennlife Beijing Technol Co Ltd, 65 North Fourth Ring Rd West, Beijing 100080, Peoples R China
Peking Univ, Dept Cardiol, Hosp 1, 8 Xi Shi Ku Da Jie St, Beijing 100034, Peoples R China
KeywordsGENOME-WIDE ASSOCIATION
T-CADHERIN
RESTENOSIS
ADIPONECTIN
CDH13
RISK
POLYMORPHISMS
METAANALYSIS
PROMOTER
LOCUS
Issue DateJan-2020
PublisherPHARMACOGENOMICS
AbstractAim: Major drawbacks of percutaneous coronary intervention are the high occurrence of repeat revascularization due to restenosis and disease progression. The aim of this study was to find genetic indicators to predict the risk of repeat revascularization. Materials & methods: From April 2015 to June 2016, 143 patients with percutaneous coronary intervention with genetic test results were enrolled. SNPs were measured by OmniZhongHua-8, and the SNPs in pathways genes related to known stenosis-related processes from the KEGG, BioCarta and Gene Cards databases were selected for analysis. Results: Cell-extracellular matrix interactions were the pathways with the most significant SNP (CDH15 rs72819363) association with repeat revascularization. Compared with CDH13 rs11859453G carriers, the adjusted odds ratio for A carriers was 0.25 and 0.33 at 18 and 30 months. Conclusion: We demonstrated a potential role of the cell-extracellular matrix interactions pathway and the possible biomarker CDH13/CDH15 in the development of coronary repeat revascularization.
URIhttp://hdl.handle.net/20.500.11897/586095
ISSN1462-2416
DOI10.2217/pgs-2019-0118
IndexedSCI(E)
Appears in Collections:第一医院

Files in This Work
There are no files associated with this item.

Web of Science®



Checked on Last Week

Scopus®



Checked on Current Time

百度学术™



Checked on Current Time

Google Scholar™





License: See PKU IR operational policies.